Insights

Growth potential MiMedx operates in wound care, burn, and surgical settings with a mid-market revenue range and a sizable employee base, indicating opportunities to cross-sell advanced healing solutions to healthcare providers expanding these service lines.

Clinical leadership As a pioneer in placental tissue therapies, MiMedx emphasizes relentless innovation, presenting a strong case for premium product demonstrations and partner programs with hospitals seeking cutting-edge regenerative wound care options.

Regulatory momentum Favorable regulatory developments around AXIOFILL and related classifications suggest momentum for market adoption, creating opportunities to position MiMedx products as compliant, industry-leading healing solutions.

Strategic partnerships Active engagement in news comparing and potentially acquiring other wound care players hints at strategic consolidation potential; sales teams can explore co-marketing, distribution alliances, and channel partnerships to expand reach.

Analyst interest Consistent buy-side coverage and analyst ratings indicate growing investor interest and visibility, which can be leveraged in client conversations to highlight stability, potential returns, and a compelling long-term adoption narrative.

Similar companies to MiMedx

MiMedx Tech Stack

MiMedx uses 8 technology products and services including IBM Cognos Analytics, Tableau, SOLIDWORKS, and more. Explore MiMedx's tech stack below.

Media & News

MiMedx's Email Address Formats

MiMedx uses at least 4 email formats:
MiMedx Email FormatsExamplePercentage
FLast@mimedx.comJDoe@mimedx.com
88%
First.Last@mimedx.comJohn.Doe@mimedx.com
9%
First@mimedx.comJohn@mimedx.com
2%
FirstLast@mimedx.comJohnDoe@mimedx.com
1%

Frequently Asked Questions

What is MiMedx's phone number?

Minus sign iconPlus sign icon
You can contact MiMedx's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is MiMedx's stock symbol?

Minus sign iconPlus sign icon
MiMedx is a publicly traded company; the company's stock symbol is MDXG.

What is MiMedx's official website and social media links?

Minus sign iconPlus sign icon
MiMedx's official website is mimedx.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does MiMedx generate?

Minus sign iconPlus sign icon
As of October 2026, MiMedx's annual revenue is estimated to be $250M - $500M.

What is MiMedx's SIC code and NAICS code?

Minus sign iconPlus sign icon
MiMedx's SIC code is 2835 - In Vitro and In Vivo Diagnostic Substances and NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does MiMedx have currently?

Minus sign iconPlus sign icon
As of October 2026, MiMedx has approximately 762 employees across 5 continents, including North America, Asia and Europe. Key team members include Chief Executive Officer: C. R., Chief Executive Officer & Founder: P. K. and Chief Scientific Officer: T. K. Explore MiMedx's employee directory with LeadIQ.

What industry does MiMedx belong to?

Minus sign iconPlus sign icon
MiMedx operates in the Medical Equipment Manufacturing industry.

What technology does MiMedx use?

Minus sign iconPlus sign icon
MiMedx's tech stack includes IBM Cognos Analytics, Tableau, SOLIDWORKS, Amazon Web Services, Figma, Smartsheet, Microsoft Teams and Adobe Creative Suite.

What is MiMedx's email format?

Minus sign iconPlus sign icon
MiMedx's email format typically follows the pattern of FLast@mimedx.com. Find more MiMedx email formats with LeadIQ.

How much funding has MiMedx raised to date?

Minus sign iconPlus sign icon
As of October 2026, MiMedx has raised $266M in funding. The last funding round occurred on May 31, 2022 for $4.6M.

When was MiMedx founded?

Minus sign iconPlus sign icon
MiMedx was founded in 2008.
MiMedx logo

MiMedx

Medical Equipment ManufacturingGeorgia, United States501-1000 Employees

MiMedx is a medical equipment manufacturer focused on products derived from placental tissue. Its portfolio serves wound care, burn, and surgical settings, with more than a decade of support for clinicians managing chronic and hard-to-heal wounds.
Headquartered in Marietta, Georgia, the company operates as a mid-sized firm within the medical devices industry. Its stated objective is to become a global provider of healing solutions, pursuing ongoing innovation to improve patients' quality of life.

Section iconCompany Overview

Phone number
Website
mimedx.com
SIC Code
2835 - In Vitro and In Vivo Diagnostic Substances
Stock Symbol
MDXG
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2008
Employees
501-1000

Section iconFunding & Financials

  • $266M

    MiMedx has raised a total of $266M of funding over 7 rounds. Their latest funding round was raised on May 31, 2022 in the amount of $4.6M as a Grant.

  • $250M - $500M

    MiMedx's revenue is estimated to be in the range of $250M - $500M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.